Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
LUYE PHARMA's Nanjing Luye Receives RMB285M Capital Injection
Recommend 1 Positive 7 Negative 0 |
||||
|
||||
|
China Cinda's Nanjing Xinan and Ningbo Cinda, as funders, entered into an agreement yesterday (26th) to provide further capital to Nanjing Luye for a total amount of RMB285 million, subscribing to approx. RMB12.616 million of Nanjing Luye's registered capital, according to LUYE PHARMA (02186.HK)'s announcement. Following completion of the capital injection, Nanjing Xinan/ Ningbo Cinda will hold 4.32%/ 2.33% shareholding in Nanjing Luye, respectively. The stake of NJ Xinshi, with China Cinda being its limited partner, in Nanjing Luye will reduce to 23.34%, while Shenzhen Luye, a subsidiary of LUYE PHARMA, will see its stake in Nanjing Luye decrease from 75% to 70.01%. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
